Soleno Therapeutics (SLNO) Research & Development (2016 - 2017)
Historic Research & Development for Soleno Therapeutics (SLNO) over the last 5 years, with Q4 2017 value amounting to $1.0 million.
- Soleno Therapeutics' Research & Development rose 25503.45% to $1.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.1 million, marking a year-over-year decrease of 1042.4%. This contributed to the annual value of $78.6 million for FY2024, which is 21191.39% up from last year.
- Latest data reveals that Soleno Therapeutics reported Research & Development of $1.0 million as of Q4 2017, which was up 25503.45% from $946000.0 recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' Research & Development registered a high of $1.8 million during Q1 2016, and its lowest value of $288141.0 during Q4 2016.
- Over the past 5 years, Soleno Therapeutics' median Research & Development value was $731000.0 (recorded in 2013), while the average stood at $799079.6.
- The largest annual percentage gain for Soleno Therapeutics' Research & Development in the last 5 years was 25503.45% (2017), contrasted with its biggest fall of 8154.63% (2017).
- Over the past 5 years, Soleno Therapeutics' Research & Development (Quarter) stood at $359832.0 in 2013, then skyrocketed by 69.31% to $609216.0 in 2014, then skyrocketed by 110.8% to $1.3 million in 2015, then crashed by 77.56% to $288141.0 in 2016, then surged by 255.03% to $1.0 million in 2017.
- Its Research & Development was $1.0 million in Q4 2017, compared to $946000.0 in Q3 2017 and $773000.0 in Q2 2017.